Micosis cutáneas prevalentes en la infancia
DOI:
https://doi.org/10.29176/2590843X.274Palabras clave:
micosis cutáneas, infancia, dermatofitosResumen
Las micosis cutáneas son un grupo de entidades que se presentan con gran frecuencia en las consultas dermatológicas y, aunque la principal población afectada son adolescentes y adultos, en la población pediátrica se ha incrementado dicha incidencia debido a múltiples factores que han hecho más frecuente el contagio persona-persona y por otras fuentes. Por tal razón, es importante tener en cuenta a la hora de evaluar un paciente en este grupo etario, las principales micosis cutáneas, su diagnóstico y manejo, para de esta manera, evitar manejos fallidos y resultados desfavorables.
Biografía del autor/a
Ana Paula Giraldo-Hoyos
Médica, Residente de Dermatología, Universidad CES, Medellín, Colombia
Nora Cardona-Castro
Médica M.Sc. Universidad CES, Instituto Colombiano de Medicina Tropical, Medellín, Colombia
Referencias bibliográficas
1. Ruiz A, Ciroco A. Micosis cutáneas en la Infancia : estudio retrospectivo desde 1990 hasta el 2001 en la consulta de micología del Servicio de Dermatología del Hospital Universitario de Caracas. Dermatol Venez. 2004;42(1):30–4.
2. Rojo J, González C. Micosis cutáneas en los niños. Pediatr Integr. 2004;8(4):271–8.
3. Sellami A, Sellami H, Makni F, Mezghani S, Cheikh-Rouhou F, Marrekchi S, et al. Childhood dermatomycoses study in Sfax Hospital, Tunisia. Mycoses. 2008 Sep;51(5):451–4.
4. Fernandes NC, Akiti T, Barreiros MG. Dermatophytoses in children: study of 137 cases. Rev. Inst. Med. trop. S. Paulo. 2001;43(2):83–5.
5. Seidl HP, Ring J, Abeck D. Pediatric Tinea Capitis: recognition and management. Am J Clin Dermatol. 2005;6(4):203–13.
6. Rebollo N, López-Barcenas AP, Arenas R. Tiña de la cabeza. Actas Dermosifiliogr. 2008 Mar;99(2):91–100.
7. Emele FE, Oyeka C a. Tinea capitis among primary school children in Anambra state of Nigeria. Mycoses. 2008 Nov;51(6):536–41.
8. Aly R. Ecology, epidemiology and diagnosis of tinea capitis. Pediatr. Infect. Dis. J. 1999 Feb;18(2):180–5.
9. Fuller LC, Child FC, Higgins EM. Tinea capitis in south-east London: an outbreak of Trichophyton tonsurans infection. Br. J. Dermatol. 1997 Jan;136(1):139.
10. Del Boz J, Crespo V, Rivas-Ruiz F, de Troya M. A 30-year survey of paediatric tinea capitis in southern Spain. J. Eur. Acad. Dermatol. Venereol. 2011 Feb;25(2):170–4.
11. Ali S, Graham TAD, Forgie SED. The assessment and management of tinea capitis in children. Pediatr. Emerg. Care. 2007 Sep;23(9):662–5; quiz 666–8.
12. Fuller LC, Child FJ, Midgley G, Higgins EM. Diagnosis and management of scalp ringworm. BMJ. 2003 Mar 8;326(7388):539–41.
13. Ginter-Hanselmayer G, Weger W, Ilkit M, Smolle J. Epidemiology of tinea capitis in Europe: current state and changing patterns. Mycoses. 2007 Jan;50 Suppl 2:6–13.
14. Benavides J, Villanueva J. Tiña del cuero cabelludo por Trichophyton tonsurans: agente emergente en Colombia. Rev Asoc Colomb Dermatol. 2010;18:99–101.
15. Santa Maria L, Vélez H, Guzmán G. DERMATOMICOSIS ANALISIS RETROSPECTIVO DE 2.336 PACIENTES, 1976-1980 [Internet]. [cited 2014 Aug 11]. Available from: http://www.actamedicacolombiana.com/anexo/articulos/06-1982-03.htm
16. Elewski BE. Tinea capitis: a current perspective. J. Am. Acad. Dermatol. 2000 Jan;42(1 Pt 1):1–20; quiz 21–4.
17. Triviño-Duran L, Torres-Rodriguez JM, Martinez-Roig A, Cortina C, Belver V, Perez-Gonzalez M, et al. Prevalence of tinea capitis and tinea pedis in Barcelona school children. Pediatr. Infect. Dis. J. 2005 Feb;24(2):137–41.
18. Marples MJ. The ecology of Microsporum canis bodin in New Zeland. J Hyg. 1956;54(3):378–87.
19. Brasch J, Gottkehaskamp D. The effect of selected human steroid hormones upon the growth of dermatophytes with different adaptation to man. Mycopathologia. 1992 Nov;120(2):87–92.
20. Pereiro Miguens M, Pereiro M. Review of dermatophytoses in Galicia from 1951 to 1987, and comparison with other areas of Spain. Mycopathologia. 1991 Feb;113(2):65–78.
21. Gilaberte Y, Rezusta A, Gil J, Sáenz-Santamaría MC, Coscojuela C, Navarro M, et al. Tinea capitis in infants in their first year of life. Br. J. Dermatol. 2004 Oct;151(4):886–90.
22. Bonifaz A. Micología Médica Básica. 4th ed. México, DF: Mc Graw-Hill; 2013. p. 100–32.
23. Chanussot C, Arenas R. querion de celso por M gypseum en niño de 5 años.pdf. Dermatol Venez. 2010;48(3):99–101.
24. Schwartz RA, Janniger CK. Tinea capitis. Cutis. 1995 Jan;55(1):29–33.
25. Gupta AK, Katz HI, Shear NH. Drug interactions with itraconazole, fluconazole, and terbinafine and their management. J. Am. Acad. Dermatol. 1999 Aug;41(2 Pt 1):237–49.
26. Bojórquez MA, Arenas R, Molina de Soschin D V-ME. Granuloma tricofítico y querión de Celso: Datos clínicos e histológicos de nueve casos. Dermatologia Rev Mex02. 2002;46:15–22.
27. Honig PJ, Caputo GL, Leyden JJ, McGinley K, Selbst SM, McGravey AR. Microbiology of kerions. J. Pediatr. 1993 Sep;123(3):422–4.
28. Babel DE, Baughman SA. Evaluation of the adult carrier state in juvenile tinea capitis caused by Trichophyton tonsurans. J. Am. Acad. Dermatol. 1989 Dec;21(6):1209–12.
29. Hebert AA. Tinea capitis. Current concepts. Arch. Dermatol. 1988 Oct;124(10):1554–7.
30. Viguié-Vallanet C, Serre M, Masliah L, Tourte-Schaefer C. [Epidemic of Trichophyton tonsurans tinea capitis in a nursery school in the Southern suburbs of Paris]. Ann. Dermatol. Venereol. 2005 May;132(5):432–8.
31. Sharma V, Hall JC, Knapp JF, Sarai S, Galloway D, Babel DE. Scalp colonization by Trichophyton tonsurans in an urban pediatric clinic. Asymptomatic carrier state. Arch. Dermatol. 1988 Oct;124(10):1511–3.
32. Kefalidou S, Odia S, Gruseck E, Schmidt T, Ring J, Abeck D. Wood’s light in Microsporum canis positive patients. Mycoses. 1997 Dec;40(11-12):461–3.
33. Elewski BE. Cutaneous mycoses in children. Br. J. Dermatol. 1996 Jun;134 Suppl:7–11: discussion 37–8.
34. Higgins EM, Fuller LC, Smith CH. Guidelines for the management of tinea capitis. British Association of Dermatologists. Br. J. Dermatol. 2000 Jul;143(1):53–8.
35. Arenas R, Toussaint S, Isa-Isa R. Kerion and dermatophytic granuloma. Mycological and histopathological findings in 19 children with inflammatory tinea capitis of the scalp. Int. J. Dermatol. 2006 Mar;45(3):215–9.
36. Sperling LC. Inflammatory tinea capitis (kerion) mimicking dissecting cellulitis. Occurrence in two adolescents. Int J Dermatol. 1991 Mar;30(3):190–2.
37. Hussain I, Muzaffar F, Rashid T, Ahmad TJ, Jahangir M, Haroon TS. A randomized, comparative trial of treatment of kerion celsi with griseofulvin plus oral prednisolone vs. griseofulvin alone. Med. Mycol. 1999 Apr;37(2):97–9.
38. Allen HB, Honig PJ, Leyden JJ, McGinley KJ. Selenium sulfide: adjunctive therapy for tinea capitis. Pediatrics. 1982 Jan;69(1):81–3.
39. Neil G, Hanslo D, Buccimazza S, Kibel M. Control of the carrier state of scalp dermatophytes. Pediatr. Infect. Dis. J. 1990 Jan;9(1):57–8.
40. González U, Seaton T, Bergus G, Jacobson J, Martínez-Monzón C. Systemic antifungal therapy for tinea capitis in children. Cochrane database Syst. Rev. 2007 Jan;(4):CD004685.
41. Moossavi M, Bagheri B, Scher RK. Systemic antifungal therapy. Dermatol. Clin. 2001 Jan;19(1):35–52.
42. Krafchik B, Pelletier J. An open study of tinea capitis in 50 children treated with a 2-week course of oral terbinafine. J Am Acad Dermatol. 1999 Jul;41(1):60–3.
43. Koumantaki E, Kakourou T, Rallis E, Riga P, Georgalla S. Doubled dose of oral terbinafine is required for Microsporum canis tinea capitis. Pediatr. Dermatol. 2001;18(4):339–42.
44. Nejjam F, Zagula M, Cabiac MD, Guessous N, Humbert H, Lakhdar H. Pilot study of terbinafine in children suffering from tinea capitis: evaluation of efficacy, safety and pharmacokinetics. Br. J. Dermatol. 1995 Jan;132(1):98–105.
45. Jones TC. Overview of the use of terbinafine (Lamisil) in children. Br. J. Dermatol. 1995 May;132(5):683–9.
46. Conjeevaram G, Vongthavaravat V, Sumner R, Koff RS. Terbinafine-induced hepatitis and pancytopenia. Dig. Dis. Sci. 2001 Aug;46(8):1714–6.
47. Abdel-Rahman SM, Powell DA, Nahata MC. Efficacy of itraconazole in children with Trichophyton tonsurans tinea capitis. J. Am. Acad. Dermatol. 1998 Mar;38(3):443–6.
48. Haria M, Bryson HM, Goa KL. Itraconazole. A reappraisal of its pharmacological properties and therapeutic use in the management of superficial fungal infections. Drugs. 1996 Apr;51(4):585–620.
49. Niewerth M, Korting HC. The use of systemic antimycotics in dermatotherapy. Eur. J. Dermatol. 2000 Mar;10(2):155–60.
50. Kawakami Y, Oyama N, Sakai E, Nishiyama K, Suzutani T, Yamamoto T. Childhood Tinea incognito caused by Trichophyton mentagrophytes Var. Interdigitale mimicking pustular psoriasis. Pediatr. Dermatol. 2011;28(6):738–40.
51. Sigurgeirsson B, Kristinsson KG, Jonasson PS. Onychomycosis in Icelandic children. JEADV. 2006 Aug;20(7):796–9.
52. Vásquez del Mercado E, Arenas R. Onicomicosis en niños. Estudio retrospectivo de 233 casos mexicanos. Gac Méd Méx. 2008;144(1):7–10.
53. Gupta AK, Skinner AR, Baran R. Onychomycosis in children: an overview. J. Drugs Dermatol. 2003 Jan;2(1):31–4.
54. Lange M, Nowicki R, Barańska-Rybak W, Bykowska B. Dermatophytosis in children and adolescents in Gdansk, Poland. Mycoses. 2004 Aug;47(7):326–9.
55. Romano C, Papini M, Ghilardi A, Gianni C. Onychomycosis in children: a survey of 46 cases. Mycoses. 2005 Nov;48(6):430–7.
56. Gupta AK, Skinner AR. Onychomycosis in children: a brief overview with treatment strategies. Pediatr. Dermatol. 2004;21(1):74–9.
57. Arenas R. [Onychomycosis. Clinico-epidemiological mycological and therapeutic aspects]. Gac. Med. Mex. 1990;126(2):84–9; discussion 90–1.
58. Ginter-Hanselmayer G, Weger W, Smolle J. Onychomycosis: a new emerging infectious disease in childhood population and adolescents. Report on treatment experience with terbinafine and itraconazole in 36 patients. JEADV. 2008 Apr;22(4):470–5.
59. Becerril-Chihu G, Bazán-Mora E, López-Martínez R, Sosa-de-Martínez C, Ruiz-Maldonado R. How often are dermatophytes present in apparently normal versus scaly feet of children? Pediatr. Dermatol. 1999;16(2):87–9.
60. Villanueva J, Arenas R. Candidiasis mucocutánea. Una revisión. Rev Méx Micol. 2007;25:91–104.
61. Gupta AK, Tu LQ. Onychomycosis therapies: strategies to improve efficacy. Dermatol. Clin. 2006 Jul;24(3):381–6.
62. Alam M, Scher RK. Current topics in nail surgery. J. Cutan. Med. Surg. 1999 Oct;3(6):324–35.
63. Bonifaz A, Ibarra G. Onychomycosis in children: treatment with bifonazole-urea. Pediatr. Dermatol. 2000;17(4):310–4.
64. Tosti A, Piraccini BM, Iorizzo M. Management of onychomycosis in children. Dermatol. Clin. 2003 Jul;21(3):507–9, vii.
65. Gupta AK, Cooper EA, Ginter G. Efficacy and safety of itraconazole use in children. Dermatol. Clin. 2003 Jul;21(3):521–35.
66. Baran R, Hay RJ, Garduno JI. Review of antifungal therapy, part II: treatment rationale, including specific patient populations. J. Dermatolog. Treat. 2008 Jan;19(3):168–75.
67. Palacios CP, Gómez LM, Cardona N. Candidiasis mucocutánea : espectro clínico. Rev Asoc Colomb Dermatol. 2011;19:239–44.
68. López-Martínez R. Candidosis, a new challenge. Clin. Dermatol. 2010 Mar 4;28(2):178–84.
69. Sullivan DJ, Westerneng TJ, Haynes KA, Bennett DE, Coleman DC. Candida dubliniensis sp. nov.: phenotypic and molecular characterization of a novel species associated with oral candidosis in HIV-infected individuals. Microbiology. 1995;141:1507–21.
70. Farah C, Ashman R, Challacombe S. Oral candidosis. Clin. Dermatol. 2000;18(5):553–62.
71. Rushood M, McCusker C, Mazer B, Alizadehfar R, Grimbacher B, Depner M. Autosomal Dominant Cases of Chronic Mucocutaneous Candidiasis Segregates with Mutations of Signal Transducer and Activator of Transcription 1, But Not of Toll-Like Receptor 3. J Pediatr. 2013;163:277–9.
72. Lilic D, Gravenor I, Robson N, Lammas DA, Drysdale P, Calvert JE, et al. Deregulated Production of Protective Cytokines in Response to Candida albicans Infection in Patients with Chronic Mucocutaneous Candidiasis. Infect. Immun. 2003;71(10):5690–9.
73. Chen SCA, Sorrell TC. Antifungal agents. Med. J. Aust. 2007 Oct 1;187(7):404–9.
74. Park HJ, Lee YW, Choe YB, Ahn KJ. Skin Characteristics in Patients with Pityriasis Versicolor Using Non-Invasive Method, MPA5. Ann. Dermatol. 2012 Nov;24(4):444–52.
75. Bonifaz A, Gómez-Daza F, Paredes V, Ponce RM. Tinea versicolor, tinea nigra, white piedra, and black piedra. Clin. Dermatol. Elsevier Inc.; 2010 Mar 4;28(2):140–5.
76. Ríos X, Rojas R, Hincapié ML. Ocho casos de piedra blanca en población pediátrica. Rev Asoc Colomb Dermatol. 2012;20(2):175–80.
77. Roshan AS, Janaki C, Parveen B. White piedra in a mother and daughter. Int. J. Trichology. 2009 Jul;1(2):140–1.
78. Muñoz VF, Díaz EE, González JL, Trejo JR. Piedra blanca en una paciente pediátrica: reporte de un caso. Rev Iberoam Micol. 2009;26(4):252–4.
79. Padilla M del C. Pitiriasis versicolor. Dermatología Rev Mex. 2005;49:157–67.
80. Bonifaz A, Badali H, de Hoog GS, Cruz M, Araiza J, Cruz M a, et al. Tinea nigra by Hortaea werneckii, a report of 22 cases from Mexico. Stud. Mycol. 2008 Jan;61:77–82.
81. Tilak R, Sinigh S, Prakash P, Singh D, Gulati A. A case report for tinea nigra in north India. Indian J Dermatol Venereol Leprol. 2009;75(5):538–9.
82. Khandpur S, Reddy BS. Itraconazole therapy for white piedra affecting scalp hair. J. Am. Acad. Dermatol. 2002 Sep;47(3):415–8.
2. Rojo J, González C. Micosis cutáneas en los niños. Pediatr Integr. 2004;8(4):271–8.
3. Sellami A, Sellami H, Makni F, Mezghani S, Cheikh-Rouhou F, Marrekchi S, et al. Childhood dermatomycoses study in Sfax Hospital, Tunisia. Mycoses. 2008 Sep;51(5):451–4.
4. Fernandes NC, Akiti T, Barreiros MG. Dermatophytoses in children: study of 137 cases. Rev. Inst. Med. trop. S. Paulo. 2001;43(2):83–5.
5. Seidl HP, Ring J, Abeck D. Pediatric Tinea Capitis: recognition and management. Am J Clin Dermatol. 2005;6(4):203–13.
6. Rebollo N, López-Barcenas AP, Arenas R. Tiña de la cabeza. Actas Dermosifiliogr. 2008 Mar;99(2):91–100.
7. Emele FE, Oyeka C a. Tinea capitis among primary school children in Anambra state of Nigeria. Mycoses. 2008 Nov;51(6):536–41.
8. Aly R. Ecology, epidemiology and diagnosis of tinea capitis. Pediatr. Infect. Dis. J. 1999 Feb;18(2):180–5.
9. Fuller LC, Child FC, Higgins EM. Tinea capitis in south-east London: an outbreak of Trichophyton tonsurans infection. Br. J. Dermatol. 1997 Jan;136(1):139.
10. Del Boz J, Crespo V, Rivas-Ruiz F, de Troya M. A 30-year survey of paediatric tinea capitis in southern Spain. J. Eur. Acad. Dermatol. Venereol. 2011 Feb;25(2):170–4.
11. Ali S, Graham TAD, Forgie SED. The assessment and management of tinea capitis in children. Pediatr. Emerg. Care. 2007 Sep;23(9):662–5; quiz 666–8.
12. Fuller LC, Child FJ, Midgley G, Higgins EM. Diagnosis and management of scalp ringworm. BMJ. 2003 Mar 8;326(7388):539–41.
13. Ginter-Hanselmayer G, Weger W, Ilkit M, Smolle J. Epidemiology of tinea capitis in Europe: current state and changing patterns. Mycoses. 2007 Jan;50 Suppl 2:6–13.
14. Benavides J, Villanueva J. Tiña del cuero cabelludo por Trichophyton tonsurans: agente emergente en Colombia. Rev Asoc Colomb Dermatol. 2010;18:99–101.
15. Santa Maria L, Vélez H, Guzmán G. DERMATOMICOSIS ANALISIS RETROSPECTIVO DE 2.336 PACIENTES, 1976-1980 [Internet]. [cited 2014 Aug 11]. Available from: http://www.actamedicacolombiana.com/anexo/articulos/06-1982-03.htm
16. Elewski BE. Tinea capitis: a current perspective. J. Am. Acad. Dermatol. 2000 Jan;42(1 Pt 1):1–20; quiz 21–4.
17. Triviño-Duran L, Torres-Rodriguez JM, Martinez-Roig A, Cortina C, Belver V, Perez-Gonzalez M, et al. Prevalence of tinea capitis and tinea pedis in Barcelona school children. Pediatr. Infect. Dis. J. 2005 Feb;24(2):137–41.
18. Marples MJ. The ecology of Microsporum canis bodin in New Zeland. J Hyg. 1956;54(3):378–87.
19. Brasch J, Gottkehaskamp D. The effect of selected human steroid hormones upon the growth of dermatophytes with different adaptation to man. Mycopathologia. 1992 Nov;120(2):87–92.
20. Pereiro Miguens M, Pereiro M. Review of dermatophytoses in Galicia from 1951 to 1987, and comparison with other areas of Spain. Mycopathologia. 1991 Feb;113(2):65–78.
21. Gilaberte Y, Rezusta A, Gil J, Sáenz-Santamaría MC, Coscojuela C, Navarro M, et al. Tinea capitis in infants in their first year of life. Br. J. Dermatol. 2004 Oct;151(4):886–90.
22. Bonifaz A. Micología Médica Básica. 4th ed. México, DF: Mc Graw-Hill; 2013. p. 100–32.
23. Chanussot C, Arenas R. querion de celso por M gypseum en niño de 5 años.pdf. Dermatol Venez. 2010;48(3):99–101.
24. Schwartz RA, Janniger CK. Tinea capitis. Cutis. 1995 Jan;55(1):29–33.
25. Gupta AK, Katz HI, Shear NH. Drug interactions with itraconazole, fluconazole, and terbinafine and their management. J. Am. Acad. Dermatol. 1999 Aug;41(2 Pt 1):237–49.
26. Bojórquez MA, Arenas R, Molina de Soschin D V-ME. Granuloma tricofítico y querión de Celso: Datos clínicos e histológicos de nueve casos. Dermatologia Rev Mex02. 2002;46:15–22.
27. Honig PJ, Caputo GL, Leyden JJ, McGinley K, Selbst SM, McGravey AR. Microbiology of kerions. J. Pediatr. 1993 Sep;123(3):422–4.
28. Babel DE, Baughman SA. Evaluation of the adult carrier state in juvenile tinea capitis caused by Trichophyton tonsurans. J. Am. Acad. Dermatol. 1989 Dec;21(6):1209–12.
29. Hebert AA. Tinea capitis. Current concepts. Arch. Dermatol. 1988 Oct;124(10):1554–7.
30. Viguié-Vallanet C, Serre M, Masliah L, Tourte-Schaefer C. [Epidemic of Trichophyton tonsurans tinea capitis in a nursery school in the Southern suburbs of Paris]. Ann. Dermatol. Venereol. 2005 May;132(5):432–8.
31. Sharma V, Hall JC, Knapp JF, Sarai S, Galloway D, Babel DE. Scalp colonization by Trichophyton tonsurans in an urban pediatric clinic. Asymptomatic carrier state. Arch. Dermatol. 1988 Oct;124(10):1511–3.
32. Kefalidou S, Odia S, Gruseck E, Schmidt T, Ring J, Abeck D. Wood’s light in Microsporum canis positive patients. Mycoses. 1997 Dec;40(11-12):461–3.
33. Elewski BE. Cutaneous mycoses in children. Br. J. Dermatol. 1996 Jun;134 Suppl:7–11: discussion 37–8.
34. Higgins EM, Fuller LC, Smith CH. Guidelines for the management of tinea capitis. British Association of Dermatologists. Br. J. Dermatol. 2000 Jul;143(1):53–8.
35. Arenas R, Toussaint S, Isa-Isa R. Kerion and dermatophytic granuloma. Mycological and histopathological findings in 19 children with inflammatory tinea capitis of the scalp. Int. J. Dermatol. 2006 Mar;45(3):215–9.
36. Sperling LC. Inflammatory tinea capitis (kerion) mimicking dissecting cellulitis. Occurrence in two adolescents. Int J Dermatol. 1991 Mar;30(3):190–2.
37. Hussain I, Muzaffar F, Rashid T, Ahmad TJ, Jahangir M, Haroon TS. A randomized, comparative trial of treatment of kerion celsi with griseofulvin plus oral prednisolone vs. griseofulvin alone. Med. Mycol. 1999 Apr;37(2):97–9.
38. Allen HB, Honig PJ, Leyden JJ, McGinley KJ. Selenium sulfide: adjunctive therapy for tinea capitis. Pediatrics. 1982 Jan;69(1):81–3.
39. Neil G, Hanslo D, Buccimazza S, Kibel M. Control of the carrier state of scalp dermatophytes. Pediatr. Infect. Dis. J. 1990 Jan;9(1):57–8.
40. González U, Seaton T, Bergus G, Jacobson J, Martínez-Monzón C. Systemic antifungal therapy for tinea capitis in children. Cochrane database Syst. Rev. 2007 Jan;(4):CD004685.
41. Moossavi M, Bagheri B, Scher RK. Systemic antifungal therapy. Dermatol. Clin. 2001 Jan;19(1):35–52.
42. Krafchik B, Pelletier J. An open study of tinea capitis in 50 children treated with a 2-week course of oral terbinafine. J Am Acad Dermatol. 1999 Jul;41(1):60–3.
43. Koumantaki E, Kakourou T, Rallis E, Riga P, Georgalla S. Doubled dose of oral terbinafine is required for Microsporum canis tinea capitis. Pediatr. Dermatol. 2001;18(4):339–42.
44. Nejjam F, Zagula M, Cabiac MD, Guessous N, Humbert H, Lakhdar H. Pilot study of terbinafine in children suffering from tinea capitis: evaluation of efficacy, safety and pharmacokinetics. Br. J. Dermatol. 1995 Jan;132(1):98–105.
45. Jones TC. Overview of the use of terbinafine (Lamisil) in children. Br. J. Dermatol. 1995 May;132(5):683–9.
46. Conjeevaram G, Vongthavaravat V, Sumner R, Koff RS. Terbinafine-induced hepatitis and pancytopenia. Dig. Dis. Sci. 2001 Aug;46(8):1714–6.
47. Abdel-Rahman SM, Powell DA, Nahata MC. Efficacy of itraconazole in children with Trichophyton tonsurans tinea capitis. J. Am. Acad. Dermatol. 1998 Mar;38(3):443–6.
48. Haria M, Bryson HM, Goa KL. Itraconazole. A reappraisal of its pharmacological properties and therapeutic use in the management of superficial fungal infections. Drugs. 1996 Apr;51(4):585–620.
49. Niewerth M, Korting HC. The use of systemic antimycotics in dermatotherapy. Eur. J. Dermatol. 2000 Mar;10(2):155–60.
50. Kawakami Y, Oyama N, Sakai E, Nishiyama K, Suzutani T, Yamamoto T. Childhood Tinea incognito caused by Trichophyton mentagrophytes Var. Interdigitale mimicking pustular psoriasis. Pediatr. Dermatol. 2011;28(6):738–40.
51. Sigurgeirsson B, Kristinsson KG, Jonasson PS. Onychomycosis in Icelandic children. JEADV. 2006 Aug;20(7):796–9.
52. Vásquez del Mercado E, Arenas R. Onicomicosis en niños. Estudio retrospectivo de 233 casos mexicanos. Gac Méd Méx. 2008;144(1):7–10.
53. Gupta AK, Skinner AR, Baran R. Onychomycosis in children: an overview. J. Drugs Dermatol. 2003 Jan;2(1):31–4.
54. Lange M, Nowicki R, Barańska-Rybak W, Bykowska B. Dermatophytosis in children and adolescents in Gdansk, Poland. Mycoses. 2004 Aug;47(7):326–9.
55. Romano C, Papini M, Ghilardi A, Gianni C. Onychomycosis in children: a survey of 46 cases. Mycoses. 2005 Nov;48(6):430–7.
56. Gupta AK, Skinner AR. Onychomycosis in children: a brief overview with treatment strategies. Pediatr. Dermatol. 2004;21(1):74–9.
57. Arenas R. [Onychomycosis. Clinico-epidemiological mycological and therapeutic aspects]. Gac. Med. Mex. 1990;126(2):84–9; discussion 90–1.
58. Ginter-Hanselmayer G, Weger W, Smolle J. Onychomycosis: a new emerging infectious disease in childhood population and adolescents. Report on treatment experience with terbinafine and itraconazole in 36 patients. JEADV. 2008 Apr;22(4):470–5.
59. Becerril-Chihu G, Bazán-Mora E, López-Martínez R, Sosa-de-Martínez C, Ruiz-Maldonado R. How often are dermatophytes present in apparently normal versus scaly feet of children? Pediatr. Dermatol. 1999;16(2):87–9.
60. Villanueva J, Arenas R. Candidiasis mucocutánea. Una revisión. Rev Méx Micol. 2007;25:91–104.
61. Gupta AK, Tu LQ. Onychomycosis therapies: strategies to improve efficacy. Dermatol. Clin. 2006 Jul;24(3):381–6.
62. Alam M, Scher RK. Current topics in nail surgery. J. Cutan. Med. Surg. 1999 Oct;3(6):324–35.
63. Bonifaz A, Ibarra G. Onychomycosis in children: treatment with bifonazole-urea. Pediatr. Dermatol. 2000;17(4):310–4.
64. Tosti A, Piraccini BM, Iorizzo M. Management of onychomycosis in children. Dermatol. Clin. 2003 Jul;21(3):507–9, vii.
65. Gupta AK, Cooper EA, Ginter G. Efficacy and safety of itraconazole use in children. Dermatol. Clin. 2003 Jul;21(3):521–35.
66. Baran R, Hay RJ, Garduno JI. Review of antifungal therapy, part II: treatment rationale, including specific patient populations. J. Dermatolog. Treat. 2008 Jan;19(3):168–75.
67. Palacios CP, Gómez LM, Cardona N. Candidiasis mucocutánea : espectro clínico. Rev Asoc Colomb Dermatol. 2011;19:239–44.
68. López-Martínez R. Candidosis, a new challenge. Clin. Dermatol. 2010 Mar 4;28(2):178–84.
69. Sullivan DJ, Westerneng TJ, Haynes KA, Bennett DE, Coleman DC. Candida dubliniensis sp. nov.: phenotypic and molecular characterization of a novel species associated with oral candidosis in HIV-infected individuals. Microbiology. 1995;141:1507–21.
70. Farah C, Ashman R, Challacombe S. Oral candidosis. Clin. Dermatol. 2000;18(5):553–62.
71. Rushood M, McCusker C, Mazer B, Alizadehfar R, Grimbacher B, Depner M. Autosomal Dominant Cases of Chronic Mucocutaneous Candidiasis Segregates with Mutations of Signal Transducer and Activator of Transcription 1, But Not of Toll-Like Receptor 3. J Pediatr. 2013;163:277–9.
72. Lilic D, Gravenor I, Robson N, Lammas DA, Drysdale P, Calvert JE, et al. Deregulated Production of Protective Cytokines in Response to Candida albicans Infection in Patients with Chronic Mucocutaneous Candidiasis. Infect. Immun. 2003;71(10):5690–9.
73. Chen SCA, Sorrell TC. Antifungal agents. Med. J. Aust. 2007 Oct 1;187(7):404–9.
74. Park HJ, Lee YW, Choe YB, Ahn KJ. Skin Characteristics in Patients with Pityriasis Versicolor Using Non-Invasive Method, MPA5. Ann. Dermatol. 2012 Nov;24(4):444–52.
75. Bonifaz A, Gómez-Daza F, Paredes V, Ponce RM. Tinea versicolor, tinea nigra, white piedra, and black piedra. Clin. Dermatol. Elsevier Inc.; 2010 Mar 4;28(2):140–5.
76. Ríos X, Rojas R, Hincapié ML. Ocho casos de piedra blanca en población pediátrica. Rev Asoc Colomb Dermatol. 2012;20(2):175–80.
77. Roshan AS, Janaki C, Parveen B. White piedra in a mother and daughter. Int. J. Trichology. 2009 Jul;1(2):140–1.
78. Muñoz VF, Díaz EE, González JL, Trejo JR. Piedra blanca en una paciente pediátrica: reporte de un caso. Rev Iberoam Micol. 2009;26(4):252–4.
79. Padilla M del C. Pitiriasis versicolor. Dermatología Rev Mex. 2005;49:157–67.
80. Bonifaz A, Badali H, de Hoog GS, Cruz M, Araiza J, Cruz M a, et al. Tinea nigra by Hortaea werneckii, a report of 22 cases from Mexico. Stud. Mycol. 2008 Jan;61:77–82.
81. Tilak R, Sinigh S, Prakash P, Singh D, Gulati A. A case report for tinea nigra in north India. Indian J Dermatol Venereol Leprol. 2009;75(5):538–9.
82. Khandpur S, Reddy BS. Itraconazole therapy for white piedra affecting scalp hair. J. Am. Acad. Dermatol. 2002 Sep;47(3):415–8.
Cómo citar
1.
Giraldo-Hoyos AP, Cardona-Castro N. Micosis cutáneas prevalentes en la infancia. rev. asoc. colomb. dermatol. cir. dematol. [Internet]. 1 de julio de 2014 [citado 23 de abril de 2024];22(3):211-2. Disponible en: https://revista.asocolderma.org.co/index.php/asocolderma/article/view/274
Descargas
Los datos de descargas todavía no están disponibles.
Descargas
Publicado
2014-07-01
Cómo citar
1.
Giraldo-Hoyos AP, Cardona-Castro N. Micosis cutáneas prevalentes en la infancia. rev. asoc. colomb. dermatol. cir. dematol. [Internet]. 1 de julio de 2014 [citado 23 de abril de 2024];22(3):211-2. Disponible en: https://revista.asocolderma.org.co/index.php/asocolderma/article/view/274
Número
Sección
Artículo de revisión
| Estadísticas de artículo | |
|---|---|
| Vistas de resúmenes | |
| Vistas de PDF | |
| Descargas de PDF | |
| Vistas de HTML | |
| Otras vistas | |
